Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|March 5, 2004
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancerK J Savinainen, M J Linja, O R Saramäki, et al.
The Journal of Urology|May 9, 2001
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancerJ Isola, A Auvinen, M Poutiainen, et al.
British Journal of Cancer|January 14, 2012
Changes in circulating microRNA levels associated with prostate cancerR J Bryant, T Pawlowski, J W F Catto, et al.
Cancer Research|January 15, 1997
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancerP Koivisto, J Kononen, C Palmberg, et al.
Oncogene|January 24, 2012
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancerS E Jalava, A Urbanucci, L Latonen, et al.
Oncogene|September 13, 2011
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancerA Urbanucci, B Sahu, J Seppälä, et al.
The Journal of Pathology|May 16, 2007
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancerH E Mäki, O R Saramäki, L Shatkina, et al.
Oncogene|July 19, 2011
Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancerE S Martens-Uzunova, S E Jalava, N F Dits, et al.
Cancer Research|April 11, 2015
miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin ExpressionE Zoni, G van der Horst, A F van de Merbel, et al.
Oncogene|February 6, 2026
Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancerG N Brooke, D A Leach, R L Culley, et al.
Pageof 8